The primary treatment strategy (i.e., TSS or DAs), patient age, cardiovascular risk factors, baseline PRL levels, and the prevalence of macroprolactinoma or adenomas with cavernous sinus invasion were not significantly different between patients with and without ED. This evidence concerns the gene PRL and adenoma.